BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28618962)

  • 21. Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
    Yang F; Jiang X; Song L; Wang H; Mei Z; Xu Z; Xing N
    Oncol Rep; 2016 Mar; 35(3):1602-10. PubMed ID: 26676551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive reduction in poly-ADP-ribosylation of histone proteins during Dalton's lymphoma induced ascites tumorigenesis in mice.
    Jaylata Devi B; Sharan RN
    Cancer Lett; 2006 Jul; 238(1):135-41. PubMed ID: 16126336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and an angiolytic role of novel piperazine-benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development.
    Al-Ghorbani M; Pavankumar GS; Naveen P; Thirusangu P; Prabhakar BT; Khanum SA
    Bioorg Chem; 2016 Apr; 65():110-7. PubMed ID: 26918263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling Pathways.
    Gloger M; Menzel L; Grau M; Vion AC; Anagnostopoulos I; Zapukhlyak M; Gerlach K; Kammertöns T; Hehlgans T; Zschummel M; Lenz G; Gerhardt H; Höpken UE; Rehm A
    Cancer Res; 2020 Mar; 80(6):1316-1329. PubMed ID: 31932457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients.
    Igreja C; Courinha M; Cachaço AS; Pereira T; Cabeçadas J; da Silva MG; Dias S
    Haematologica; 2007 Apr; 92(4):469-77. PubMed ID: 17488657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent.
    Zhang Q; Lin Z; Yin X; Tang L; Luo H; Li H; Zhang Y; Luo W
    Eur J Pharmacol; 2016 May; 779():138-46. PubMed ID: 26968484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
    Laborda-Illanes A; Sánchez-Alcoholado L; Castellano-Castillo D; Boutriq S; Plaza-Andrades I; Aranega-Martín L; Peralta-Linero J; Alba E; González-González A; Queipo-Ortuño MI
    Biomed Pharmacother; 2023 Jan; 157():114041. PubMed ID: 36423543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
    Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
    Pratheeshkumar P; Kuttan G
    Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New role of lupeol in reticence of angiogenesis, the cellular parameter of neoplastic progression in tumorigenesis models through altered gene expression.
    Vijay Avin BR; Prabhu T; Ramesh CK; Vigneshwaran V; Riaz M; Jayashree K; Prabhakar BT
    Biochem Biophys Res Commun; 2014 May; 448(2):139-44. PubMed ID: 24780400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.
    Jardim-Perassi BV; Arbab AS; Ferreira LC; Borin TF; Varma NR; Iskander AS; Shankar A; Ali MM; de Campos Zuccari DA
    PLoS One; 2014; 9(1):e85311. PubMed ID: 24416386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
    Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
    Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
    Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model.
    Sriram MI; Kanth SB; Kalishwaralal K; Gurunathan S
    Int J Nanomedicine; 2010 Oct; 5():753-62. PubMed ID: 21042421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.